Inovio Pharmaceuticals (INO) Competitors $1.98 -0.15 (-7.04%) Closing price 04:00 PM EasternExtended Trading$1.98 0.00 (-0.25%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INO vs. STIM, SNWV, ZIMV, TCMD, NVRO, SKIN, NYXH, DRTS, ELMD, and RCELShould you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), Nevro (NVRO), Beauty Health (SKIN), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Electromed (ELMD), and AVITA Medical (RCEL). These companies are all part of the "medical equipment" industry. Inovio Pharmaceuticals vs. Neuronetics SANUWAVE Health ZimVie Tactile Systems Technology Nevro Beauty Health Nyxoah Alpha Tau Medical Electromed AVITA Medical Inovio Pharmaceuticals (NASDAQ:INO) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership. Do insiders and institutionals hold more shares of INO or STIM? 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 2.3% of Inovio Pharmaceuticals shares are held by company insiders. Comparatively, 8.7% of Neuronetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate INO or STIM? Inovio Pharmaceuticals presently has a consensus target price of $9.75, suggesting a potential upside of 392.42%. Neuronetics has a consensus target price of $5.50, suggesting a potential upside of 37.16%. Given Inovio Pharmaceuticals' higher probable upside, equities analysts clearly believe Inovio Pharmaceuticals is more favorable than Neuronetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Neuronetics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer INO or STIM? In the previous week, Inovio Pharmaceuticals had 9 more articles in the media than Neuronetics. MarketBeat recorded 11 mentions for Inovio Pharmaceuticals and 2 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.39 beat Inovio Pharmaceuticals' score of 0.18 indicating that Neuronetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inovio Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Neuronetics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is INO or STIM more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Neuronetics' net margin of -50.09%. Inovio Pharmaceuticals' return on equity of -118.17% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -118.17% -83.47% Neuronetics -50.09%-141.24%-32.77% Which has preferable earnings and valuation, INO or STIM? Neuronetics has higher revenue and earnings than Inovio Pharmaceuticals. Neuronetics is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$283.10K256.50-$135.12M-$3.19-0.62Neuronetics$89.45M2.95-$30.19M-$1.31-3.06 Which has more volatility and risk, INO or STIM? Inovio Pharmaceuticals has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Neuronetics has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Does the MarketBeat Community favor INO or STIM? Inovio Pharmaceuticals received 592 more outperform votes than Neuronetics when rated by MarketBeat users. Likewise, 70.69% of users gave Inovio Pharmaceuticals an outperform vote while only 68.62% of users gave Neuronetics an outperform vote. CompanyUnderperformOutperformInovio PharmaceuticalsOutperform Votes72170.69% Underperform Votes29929.31% NeuroneticsOutperform Votes12968.62% Underperform Votes5931.38% SummaryNeuronetics beats Inovio Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INO vs. The Competition Export to ExcelMetricInovio PharmaceuticalsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.62M$4.47B$5.35B$8.38BDividend YieldN/A43.64%5.22%4.10%P/E Ratio-0.6229.4326.8419.71Price / Sales256.5067.72391.39116.98Price / CashN/A51.0838.2534.62Price / Book0.386.236.794.50Net Income-$135.12M$68.16M$3.23B$248.18M7 Day Performance5.32%18.33%4.07%1.14%1 Month Performance11.24%23.04%12.52%15.20%1 Year Performance-81.98%20.61%16.83%6.56% Inovio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOInovio Pharmaceuticals3.6612 of 5 stars$1.98-7.0%$9.75+392.4%-80.8%$72.62M$283,099.00-0.62320STIMNeuronetics1.9202 of 5 stars$4.14-6.5%$5.50+32.9%+69.6%$272.47M$74.89M-3.37180SNWVSANUWAVE HealthN/A$30.55+1.5%N/AN/A$261.17M$32.63M-6.7040ZIMVZimVie2.2004 of 5 stars$8.91+1.7%$19.50+118.9%-47.9%$248.12M$449.75M-0.682,700TCMDTactile Systems Technology3.3801 of 5 stars$9.72+1.9%$16.00+64.6%-23.8%$230.03M$292.98M13.89980NVRONevro0.1931 of 5 stars$5.85+0.1%$5.36-8.3%-44.4%$224.32M$408.52M-3.091,090News CoverageSKINBeauty Health0.3638 of 5 stars$1.76-5.9%$2.45+39.2%-34.7%$220.43M$322.47M-4.191,030Trending NewsHigh Trading VolumeNYXHNyxoah2.9041 of 5 stars$5.98-5.1%$14.50+142.5%-23.0%$203.68M$4.52M-3.20110Earnings ReportGap UpDRTSAlpha Tau Medical2.0377 of 5 stars$2.80-5.1%$8.00+185.7%+20.3%$197.07MN/A-6.5180News CoverageEarnings ReportELMDElectromed1.2125 of 5 stars$22.44+0.8%$38.00+69.3%+31.6%$192.02M$59.63M29.92160News CoveragePositive NewsRCELAVITA Medical1.423 of 5 stars$7.25+4.0%$17.25+137.9%-18.0%$191.65M$64.25M-3.03130Gap UpHigh Trading Volume Related Companies and Tools Related Companies Neuronetics Alternatives SANUWAVE Health Alternatives ZimVie Alternatives Tactile Systems Technology Alternatives Nevro Alternatives Beauty Health Alternatives Nyxoah Alternatives Alpha Tau Medical Alternatives Electromed Alternatives AVITA Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INO Stock Free INO Stock Alerts